Should CSL (ASX:CSL) be your next dividend share?

Should CSL Limited (ASX: CSL) be your next ASX dividend share? The 1.04% yield may look paltry, but sometimes it's the growth that counts.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

CSL Limited (ASX: CSL) has never had much of a reputation as an ASX dividend share. Especially when compared to its companions in the upper echelons of the S&P/ASX 200 Index (ASX: XJO). Think about it. CSL is now the third-largest ASX 200 share by market capitalisation. Gold and silver go to Commonwealth Bank of Australia (ASX: CBA) and BHP Group Ltd (ASX: BHP). And below CSL are the other 3 remaining big banks.

All of these other companies are (or at least were, pre-COVID) dividend heavyweights.

And yet CSL has never enjoyed such a reputation. Even today, the company offers a trailing dividend yield of 1.04% – not really 'set the world on fire' stuff. And that's not even following a COVID-induced dividend cut from last year. In fact, 2020 saw CSL dole out its highest dividends in history with a combined US$2.02 per share payout. 2021 so far has seen an interim dividend of US$1.04 per share, healthily exceeding 2020's interim dividend of 95 cents.

A man happily kisses a $50 note scrunched up in his hands representing the best ASX dividend stocks in Australia today

Image source: Getty Images

CSL's dividend growth

CSL has been around in some form for over a hundred years. But it only paid its first dividends in 2013. That was a combined payment of US$1.02 per share. That means that CSL has grown its annual dividend since 2013 by a compounded annual growth rate of 10.25% per annum.

Here's an interesting number for you. Back in October 2013, when CSL paid its first final dividend, CSL shares were going for roughly $66 apiece. Using today's exchange rate, that would have equated to a rough annual yield of around 2% at the time for an investor who picked up CSL back then. But if that investor held those CSL shares until today, the yield they would have gotten on their original investment would be around 4% today with CSL's dividend growth.

That's the power of a compounding growth rate. If CSL continues to increase its dividends by an average of 10.25% every year, that yield-on-cost will only grow larger, and exponentially so, in the years ahead.

So although a 1.04% trailing dividend yield might look a little paltry, CSL's history of strong dividend growth proves that sometimes it's not just size that matters.

Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A cool white-bearded man holds his hand up signalling you should halt.
Healthcare Shares

ASX 300 cannabis stock Incannex suspended ahead of 'material update'

The Incannex share price is frozen at 14 cents for now.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Guess which ASX All Ords stock is rocketing 27% on a new FDA approval

Rett Syndrome has finally got an approved treatment.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

Buy these excellent ASX 200 healthcare shares: Goldman Sachs

Goldman has spoken very positively about these healthcare shares this week.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

Should I buy CSL shares while they're under $300?

Can investors make a healthy return with this biotech?

Read more »

A man wearing a white coat holds his hands up and mouth open with joy.
Healthcare Shares

Mesoblast share price rockets 23% on FDA news

Mesoblast has received some good news for the US FDA this morning.

Read more »

A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads some news.
Healthcare Shares

Owners of this ASX 200 share are soon going to receive a bigger dividend

Investors in this healthcare company are about to get a healthy cash boost.

Read more »

an older couple look happy as they sit at a laptop computer in their home.
Healthcare Shares

Hoping to collect the latest CSL dividend? Here's how

The next CSL dividend is fast approaching.

Read more »